Ferroptosis, a form of controlled cell death, has received enormous media attention for its causal
influence on the development and progression of chronic illnesses such as cancer. In contrast to
apoptosis, ferroptosis causes iron-dependent peroxidation
of lipids and death. More recently, ferroptosis has been shown to inhibit tumor growth and make many
cancers more susceptible to chemotherapy and immunotherapy. That makes ferroptosis a promising
candidate for novel cancer
treatments. At Creative Biolabs, we have developed a comprehensive tumor ferroptosis analysis
platform to assist in the identification and development of novel ferroptosis therapeutic
approaches.
Our platform is built to rationally seek and test novel ferroptosis targets, discover how they work,
and learn how they might work in combination with other cancer therapies.
Fig.1 Molecular basis of
ferroptosis and strategies for therapeutic induction of ferroptosis.1